Dynamic Technology Lab Private LTD Nuvalent, Inc. Transaction History
Dynamic Technology Lab Private LTD
- $601 Million
- Q4 2024
A detailed history of Dynamic Technology Lab Private LTD transactions in Nuvalent, Inc. stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 8,932 shares of NUVL stock, worth $660,342. This represents 0.12% of its overall portfolio holdings.
Number of Shares
8,932Holding current value
$660,342% of portfolio
0.12%Shares
2 transactions
Others Institutions Holding NUVL
# of Institutions
231Shares Held
57.7MCall Options Held
834KPut Options Held
490K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.33 Billion34.87% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.36MShares$397 Million16.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$333 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$224 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.62MShares$194 Million6.84% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.18B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...